Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.17B 3.73B 475M 426M 394M 357M 667M 45.25B 675M 4.71B 1.88B 23.68B 1.78B 1.75B 75.16B P/E 2026 *
6.97x
P/E 2027 * 6.18x
Enterprise Value 3.17B 3.73B 475M 426M 394M 357M 667M 45.25B 675M 4.71B 1.88B 23.68B 1.78B 1.75B 75.16B EV / Sales 2026 *
0.45x
EV / Sales 2027 * 0.42x
Free-Float
45.7%
Yield 2026 *
6.47%
Yield 2027 * 7.28%
Aug. 28 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
Aug. 28 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
Jul. 09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
Jun. 29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
Jun. 29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
Jun. 12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
May. 26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
Apr. 27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
Mar. 30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
Mar. 27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
Mar. 27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
Feb. 06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day-0.85%
1 week-5.37%
Current month-6.73%
1 month-5.52%
3 months-17.56%
6 months-24.22%
Current year-34.01%
1 week 2.88
Extreme 2.88
3.06
1 month 2.88
Extreme 2.88
3.2
Current year 2.88
Extreme 2.88
4.56
1 year 2.88
Extreme 2.88
4.95
3 years 2.88
Extreme 2.88
7.03
5 years 2.88
Extreme 2.88
9.28
10 years 2.88
Extreme 2.88
15.42
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-03
Comptroller/Controller/Auditor 48 2025-06-03
Corporate Secretary 37 2026-07-08
Director TitleAgeSince
Director/Board Member 67 2011-02-09
Director/Board Member 69 2018-06-11
Director/Board Member 82 2018-06-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-5.37%-37.15%-51.50% 479M
+6.17%+4.96%+68.59%+142.44% 1,148B
+1.35%+2.60%+47.15%+86.75% 652B
+0.88%+1.13%+28.04%+103.16% 505B
+0.73%+2.45%+54.26%+66.47% 384B
+4.96%+0.72%+71.28%+44.42% 348B
+2.38%+2.65%+34.31%+56.33% 294B
+2.26%+0.55%+3.92%+27.74% 264B
+1.40%+2.52%+57.16%+74.23% 244B
+1.17%+2.53%+36.00%+107.23% 197B
Average +2.04%+0.79%+36.36%+65.73% 403.76B
Weighted average by Cap. +3.01%+1.50%+49.90%+93.23%

Financials

2026 *2027 *
Net sales 6.98B 8.22B 1.05B 940M 869M 787M 1.47B 99.74B 1.49B 10.39B 4.14B 52.19B 3.93B 3.85B 166B 7.56B 8.9B 1.13B 1.02B 941M 852M 1.59B 108B 1.61B 11.25B 4.48B 56.53B 4.26B 4.17B 179B
Net income 454M 535M 68.17M 61.16M 56.55M 51.21M 95.68M 6.49B 96.83M 676M 269M 3.4B 256M 250M 10.79B 514M 604M 77.02M 69.1M 63.89M 57.86M 108M 7.34B 109M 764M 304M 3.84B 289M 283M 12.19B
Net Debt - -
Projected Income Statement - Annual - Tong Ren Tang Technologies Co. Ltd.
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change Volume
26-10-29 HK$2.910 -0.85% 420,000
26-10-28 HK$2.935 -1.51% 1,237,000
26-10-27 HK$2.980 -2.30% 977,886
26-10-26 HK$3.050 +2.35% 2,349,000
26-10-23 HK$2.980 -1.65% 2,176,000
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Tong Ren Tang Technologies Co. Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.473CNY
Average target price
4.601CNY
Spread / Average Target
+86.05%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tong Ren Tang Technologies Co. Ltd.
  1. Stock Market
  2. Stocks
  3. 1666 Stock